Focus on small-molecule therapeutics for infectious diseases. Combines design/synthesis and SAR with phenotypic and in vivo studies to counter antimicrobial resistance via efflux-pump inhibition and biofilm control, and advances antiviral leads using chromatography-guided bioactive profiling.